Search company, investor...

Insensys

insensys.com

Total Raised

$3.99M

Investors Count

1

Funding, Valuation & Revenue

4 Fundings

Insensys has raised $3.99M over 4 rounds.

Insensys's latest funding round was a Secondary Market for $22.85M on February 6, 2009.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

2/6/2009

Secondary Market

$22.85M

Undisclosed Investors

0

FY undefined

1

1/30/2009

Acquired

0

FY undefined

10

9/1/2005

Series A

$99M

0

FY undefined

10

10/15/2003

Seed

$99M

0

FY undefined

10

Date

2/6/2009

1/30/2009

9/1/2005

10/15/2003

Round

Secondary Market

Acquired

Series A

Seed

Amount

$22.85M

$99M

$99M

Investors

Undisclosed Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

This profile has not been claimed.

You're more than your latest funding, tell our customers your company's story.

Insensys Investors

1 Investors

Insensys has 1 investors. 3i Group invested in Insensys's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/15/2003

9/1/2005

2
Seed, Series A (2005)

Private Equity

United Kingdom

First funding

10/15/2003

Last Funding

9/1/2005

Investor

Rounds

2
Seed, Series A (2005)

Board Seats

Type

Private Equity

Location

United Kingdom

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.